Source: StreetInsider

Press Release: Zosano Pharma : Zosano Pharma to Host Conference Call on First Quarter 2018 Financial Results and Provide Operational Update

Zosano Pharma Corporation (NASDAQ: ZSAN) (“Zosano” or the “Company”) a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of therapeutics to patients using its proprietary

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Steven Lo's photo - President & CEO of Zosano Pharma

President & CEO

Steven Lo

CEO Approval Rating


Zosano Pharma is a clinical-stage biopharmaceutical company that researches, develops and commercializes novel therapeutics to treat migraines. Read more